IPP Bureau
GeneStore launches Centre of Excellence in Gurugram, India
By IPP Bureau - May 01, 2022
Center of Excellence for Molecular Diagnostics and Proteomics will enable affordable diagnostics for infectious diseases in India
Once-weekly icodec demonstrates superior reduction in HbA1c vs degludec
By IPP Bureau - April 29, 2022
In the trial, there was no statistical difference in estimated hypoglycaemia rates, and no severe hypoglycaemia events were observed for people treated with insulin icodec
Ultomiris approved in the US for adults with generalised myasthenia gravis
By IPP Bureau - April 29, 2022
Ultomiris showed early effect and lasting improvement in activities of daily living and has potential to reduce treatment burden with dosing every 8 weeks
Moderna files for authorization of its Covid-19 vaccine in young children six months to six years
By IPP Bureau - April 29, 2022
Submission to regulators globally is based on phase 2/3 studies of mRNA-1273 in young children
Philips and Prisma Health sign multi-year, long-term strategic partnership
By IPP Bureau - April 29, 2022
South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim
Camzyos is the first and only USFDA-approved cardiac myosin inhibitor
By IPP Bureau - April 29, 2022
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
Lilly's tirzepatide delivered up to 22.5% weight loss in adults with obesity
By IPP Bureau - April 29, 2022
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study
AstraZeneca expands its ‘Young Health Program’ in Delhi
By IPP Bureau - April 29, 2022
For over a decade, AstraZeneca and Plan India’s Young Health Program have been generating awareness and identifying sustainable solutions to influence the behaviour of youths against Non-Communicable Diseases
Lupin Diagnostics launches reference laboratory in Guwahati, Assam
By IPP Bureau - April 29, 2022
It is expanding the diagnostics business footprint in North East India
Medikabazaar teams up with India Health Link
By IPP Bureau - April 29, 2022
To extend the nationwide distribution network for the availability of its proprietary & award-winning HPod for corporates & doctors’ clinics, thereby strengthening India’s phygital wellness ecosystem
Ami Organics earmarks Rs 190 cr to expand API production in Ankleshwar
By IPP Bureau - April 29, 2022
The plant is expected to start commercial operations from Q4FY24
Ceryx Medical raises £3.8m in seed funding to bring cardiac device to in-human trials
By IPP Bureau - April 28, 2022
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
Dr Vijay Shetty creates an alternative to x-ray examination
By IPP Bureau - April 28, 2022
The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated
Beta Drugs announces oultook for FY 22-23
By IPP Bureau - April 28, 2022
The management believes that its strong product pipeline, diversified innovative product portfolio, continued expansion into new geographies and FGMP accreditations will help sustain the growth momentum in the coming few years
Cipla bags Pharma Leader of the Year award
By IPP Bureau - April 28, 2022
Glenmark Pharmaceuticals won Innovation of the Year award
